LENSKART.NS
LENSKART.NS
INE956O01016
LENSKART SOLUTIONS LTD
Loading chart...

Company Profile

Lenskart Solutions Limited, a technology-driven eyewear company, engages in designing, manufacturing, branding, and retailing of eyewear products in India, Japan, Southeast Asia, the Middle East, and internationally. Its products include prescription eyeglasses, sunglasses, goggles, screen glasses, and other products, such as contact lenses and eyewear accessories, including frames for men, women, and kids. The company also engages in lens manufacturing, lens edging, lens design, frame design, frame manufacturing, and delivery. It operates as a direct-to-consumer company that designs and sells a wide range of eyewear products under the Lenskart and Owndays brands; and sub brands, including John Jacobs, Vincent Chase, Hooper, Lenskart Air, Hustlr, LPL, and Meller. It sells its products through online and offline channels, such as retail stores, websites, mobile applications, and other channels. The company also owns and operates eyewear retail stores in India and provides home eye check-up services. Lenskart Solutions Limited was incorporated in 2008 and is based in Gurugram, India.

Related stocks

FPH.NZ
FPH.NZ • New Zealand
Fisher & Paykel Healthcare Corp
47.7 NZD
15.75B USD 1Y +26.9%
603087.SS
603087.SS • China
GAN&LEE PHARMACEUTICALS CO LTD
75.52 CNY
6.76B USD 1Y -0.2%
7747.T
7747.T • Japan
ASAHI INTECC CO LTD
3,363 JPY
5.64B USD 1Y +42.6%
300677.SZ
300677.SZ • China
YKYL
49 CNY
4.8B USD 1Y +33.5%
POLYMED.BO
POLYMED.BO • India
POLY MEDICURE LTD.
1,585.4 INR
1.66B USD 1Y -16.3%
ANN.AX
ANN.AX • Australia
ANSELL FPO [ANN]
45.14 AUD
4.44B USD 1Y +37.4%
300896.SZ
300896.SZ • China
IMEIK
95.03 CNY
4.3B USD 1Y -47.3%
AGARWALEYE.NS
AGARWALEYE.NS • India
DR AGARWALS HEALTH CARE L
477.75 INR
1.56B USD 1Y -5.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
3Y Volatility
-
Max Drawdown (3Y)
-
Sharpe Ratio (3Y)
-
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 176.5 (Elevated multiple compression risk)
ende